Literature DB >> 16038760

SEN virus infection among patients on maintenance hemodialysis in southern Taiwan.

Chia-Yen Dai1, Wan-Long Chuang, Wen-Yu Chang, Shinn-Cherng Chen, Ming-Hsing Sung, Ming-Yen Hsieh, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang, Jung-Fa Tsai, Ming-Lung Yu.   

Abstract

OBJECTIVES: The prevalence and clinical significance of two SEN virus (SENV) strains, SENV-D and SENV-H, was investigated among patients on maintenance hemodialysis in southern Taiwan.
METHODS: Sera from 99 uremic patients were tested for alanine aminotransferase (ALT), hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (anti-HCV), and SENV-D and -H DNA. Sera from 120 healthy blood donors were tested as a control group.
RESULTS: Of the 99 patients, 24.2 and 7.1% were positive for anti-HCV and HBsAg, respectively, and the prevalence of SENV-D and/or -H (SENV-D/H), SENV-D and SENV-H DNA was 61.6, 46.5 and 27.3%, which was significantly higher than for donors (23.3, 18.3, and 5.8%, respectively; all P<0.0001). Patients with SENV-D DNA had significantly higher mean age among both patients (P=0.019) and donors (P=0.015). Mean serum ALT levels were significantly higher among patients with anti-HCV (P=0.003) and patients with SENV-D and -H concurrent infection (P=0.034). By multivariate analyses, the presence of serum anti-HCV and concurrent SENV-D and -H infection were independent factors associated with increased ALT level.
CONCLUSIONS: The prevalence of SENV-D/H infection is high among Taiwanese patients on maintenance hemodialysis with SENV-D more prevalent than SENV-H. The ALT level was associated with not only positive anti-HCV but also concomitant viremia of both SENV-D and SENV-H.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16038760     DOI: 10.1016/j.jinf.2004.10.007

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  3 in total

1.  Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.

Authors:  Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Shinn-Cherng Chen; Li-Po Lee; Ming-Yen Hsieh; Nei-Jen Hou; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

2.  SEN virus infection in Egyptian patients with chronic hepatitis C and patients undergoing hemodialysis.

Authors:  Maisa Omar; Samah Saad El-Din; Nevine Fam; Manal Diab; Mohamed Shemis; Manar Raafat; Moataz Seyam; Moataz Hssan; Afkar Badawy; Maha Akl; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-12-24

3.  The prevalence of SEN virus among blood donors in the Eastern Province of KSA.

Authors:  Elmoeiz A Elnagi; Thekra N Al-Maqati; Yaser Alnaam; Ahmed A Adam; Ali A Rabaan; Zeinab S Mohamed; Anisah Amer; Hussa L Almarfoi
Journal:  Saudi J Biol Sci       Date:  2021-04-01       Impact factor: 4.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.